RAD Jan 2025 10.000 put
| Previous Close | 6.79 |
| Open | 6.79 |
| Bid | 6.70 |
| Ask | 6.90 |
| Strike | 10.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 6.79 - 6.79 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 43 |
Business WireRite Aid Empowers Customers to Be Themselves with Launch of RYSHI™ Beauty and Personal Care Essentials
PHILADELPHIA, June 05, 2023--Today national drug store chain Rite Aid announced the launch of RYSHI™ – its exclusive collection of clean beauty and personal care essentials designed to let the real you shine through. Spanning across multiple categories, RYSHI™ products offer better-for-you ingredients at an accessible price point so customers can conveniently build their beauty toolkit at their neighborhood Rite Aid.
Business WireElixir announces the next wave of innovation for pharmacy benefits technology platform
PHILADELPHIA, May 23, 2023--Elixir, a pharmacy benefit management company owned by Rite Aid (NYSE: RAD), has announced details of the next release of its Laker Software technology platform. The upcoming enhancements include new automated workflows, a customer service tool and modernization of the user interface.
Yahoo FinanceWhy indie pharmacies, with the help of the likes of Mark Cuban, are on the rise
Independent pharmacies and startups such as Cigna's Express Scripts and Mark Cuban's Cost Plus Drugs are partnering up to address a coverage gap for some Americans.
- Thomson Reuters StreetEvents
Q1 2023 Retail Opportunity Investments Corp Earnings Call
Q1 2023 Retail Opportunity Investments Corp Earnings Call
Business WireRite Aid Looks to ‘Ease the Sneeze’ This Allergy Season
PHILADELPHIA, April 26, 2023--It’s no secret seasonal allergies are here. From runny noses and itchy eyes to tissues carried in all pockets and bags, spring has sprung and mother nature has brought the dreaded sneeze with her. To help its suffering shoppers, Rite Aid has spent the last few weeks dusting off last season’s sales data* and speaking with real allergy victims to once and for all ‘Ease the Sneeze.’
ZacksZacks Industry Outlook Highlights CVS Health, Walgreens BootsAlliance, Rite Aid and Amazon
CVS Health, Walgreens BootsAlliance, Rite Aid and Amazon have been highlighted in this Industry Outlook article.
Zacks3 Retail Pharmacy and Drugstore Stocks to Watch in a Growing Industry
Zacks Retail Pharmacy and Drugstore industry players like CVS, WBA and RAD are likely to gain on the strength of their digital pharmacies.
ZacksRite Aid (RAD) Q4 Loss Wider Than Expected, Revenues Beat
Rite Aid's (RAD) Q4 results gain from improvements in retail pharmacy and Elixir. However, lower revenues from COVID vaccines and testing, and store closures act as headwinds.
ZacksRite Aid (RAD) Reports Q4 Loss, Tops Revenue Estimates
Rite Aid (RAD) delivered earnings and revenue surprises of -61.04% and 6.90%, respectively, for the quarter ended February 2023. Do the numbers hold clues to what lies ahead for the stock?
Business WireRite Aid Corporation Reports Fiscal 2023 Fourth Quarter and Full Year Results and Provides Fiscal 2024 Outlook
PHILADELPHIA, April 20, 2023--Rite Aid Corporation (NYSE: RAD) today reported operating results for its fourteen-week fourth quarter and fifty-three-week fiscal year ended March 4, 2023.
ZacksFactors Likely to Influence Rite Aid (RAD) in Q4 Earnings
Higher non-COVID prescriptions, strength in PBM and delivery service expansion are likely to have impacted Rite Aid's (RAD) Q4 performance amid sluggishness in Retail Pharmacy and Pharmacy Services.
Motley FoolBest Pharmacy Stock to Buy Right Now
All three major pharmacy chains, CVS Health (NYSE: CVS), Walgreens Boots Alliance (NASDAQ: WBA), and Rite Aid (NYSE: RAD), have seen their shares drop over the past 12 months and so far this year. In its guidance, the company said it expects 2023 EPS of $7.73 to $7.93.
ZacksWalgreens Boots Alliance (WBA) Q2 Earnings and Revenues Surpass Estimates
Walgreens (WBA) delivered earnings and revenue surprises of 5.45% and 4.16%, respectively, for the quarter ended February 2023. Do the numbers hold clues to what lies ahead for the stock?
Business WireRite Aid to Release Fourth Quarter Results on April 20
PHILADELPHIA, March 23, 2023--Rite Aid Corporation (NYSE: RAD) will release financial results for its Fiscal 2023 Fourth Quarter, which ended March 4, 2023, on Thursday, April 20, 2023. The company will hold an analyst call at 8:30 a.m. ET with remarks by Rite Aid's management team. The call will be broadcast at https://investors.riteaid.com.
- Reuters
UPDATE 3-US sues Rite Aid for missing opioid red flags
The U.S. government on Monday sued Rite Aid Corp, accusing the pharmacy chain of missing "red flags" as it illegally filled hundreds of thousands of prescriptions for controlled substances, including opioids. In a complaint filed in Cleveland federal court, the Department of Justice said Rite Aid repeatedly filled prescriptions from May 2014 to June 2019 that were medically unnecessary, for off-label use, or not issued in the usual course of professional practice. "The Justice Department is using every tool at our disposal to confront the opioid epidemic that is killing Americans and shattering communities across the country," Attorney General Merrick Garland said in a statement.
ReutersUS sues Rite Aid for missing opioid red flags
The U.S. government on Monday sued Rite Aid Corp, accusing the pharmacy chain of missing "red flags" as it illegally filled hundreds of thousands of prescriptions for controlled substances, including opioids. In a complaint filed in Cleveland federal court, the Department of Justice said Rite Aid repeatedly filled prescriptions from May 2014 to June 2019 that were medically unnecessary, for off-label use, or not issued in the usual course of professional practice. "The Justice Department is using every tool at our disposal to confront the opioid epidemic that is killing Americans and shattering communities across the country," Attorney General Merrick Garland said in a statement.
- Reuters
UPDATE 1-New York officials ask 3 pharmacy chains for plans on abortion drug access
New York government officials on Thursday sent a letter to pharmacy operators CVS Health Corp , Walgreens Boot Alliance and Rite Aid Corp , asking about their plans to make abortion pill mifepristone available in the state. The letter from New York Governor Kathy Hochul and Attorney General Letitia James asked the companies to respond in writing within 10 business days about their commitment to dispense mifepristone at U.S. drug regulator-certified pharmacy locations and via mail in the state.
- Reuters
New York officials ask 3 pharmacy chains for plans on abortion drug access
New York government officials on Thursday sent a letter to pharmacy operators CVS Health Corp , Walgreens Boot Alliance and Rite Aid Corp , asking about their plans to make abortion pill mifepristone available in the state. The letter from New York Governor Kathy Hochul and Attorney General Letitia James asked the companies to respond in writing within 10 business days about their commitment to dispense mifepristone at U.S. drug regulator-certified pharmacy locations and via mail in the state. Walgreens, Rite Aid and CVS did not immediately respond to Reuters' requests for comment.
- Zacks
Rite Aid (RAD) Down 23.5% in Three Months: Can it Rebound?
Despite drab demand and supply-chain headwinds, Rite Aid's (RAD) online strength, led by expanded delivery services, increased non-COVID prescriptions and cost-saving initiatives, are likely to aid.
Yahoo FinanceWalgreens internal memo says it is following the law on abortion pill distribution
Walgreens faces backlash over misperception of its intent to sell abortion pill in some states.
Simply Wall St.Investors in Rite Aid (NYSE:RAD) have unfortunately lost 89% over the last five years
Rite Aid Corporation ( NYSE:RAD ) shareholders should be happy to see the share price up 22% in the last month. But...
GOBankingRatesFood Stamps: 3 Drugstore Chains That Accept SNAP
If you receive benefits from the Supplemental Nutrition Assistance Program (SNAP), you might wonder if you can pay for items at your local drugstore with that money. The answer is yes, but only...
Zacks3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds
The Zacks Retail Pharmacy and Drugstore industry players like CVS, WBA and RAD are likely to gain despite reimbursement challenges hurting the overall industry health.
ZacksWhy Is Rite Aid (RAD) Down 7% Since Last Earnings Report?
Rite Aid (RAD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.